SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Current viral risks of blood and blood products
11 references·5 citing·24 second hop
Current viral risks of blood and blood products (2000)Current viral risks of blood and blood pr…The Risk of Transfusion-Transmitted Viral Infections (1996)The Risk of Transfusion-Trans…Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Estimated Risk of Transmissio…Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study (1995)Declining value of alanine am…Transmission of Retroviruses from Seronegative Donors by Transfusion during Cardiac Surgery (1992)Transmission of Retroviruses …Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV‐1 antibody screening (1991)Risk of human immunodeficienc…Evaluation of Screened Blood Donations for Human Immunodeficiency Virus Type 1 Infection by Culture and DNA Amplification of Pooled Cells (1991)Evaluation of Screened Blood …Exposure of Patients to Human Immunodeficiency Virus through the Transfusion of Blood Components That Test Antibody-Negative (1989)Exposure of Patients to Human…Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV Antibody (1988)Transmission of Human Immunod…Prevalence of HTLV-III Antibody in American Blood Donors (1985)Prevalence of HTLV-III Antibo…Donor transaminase and recipient hepatitis. Impact on blood transfusion services (1981)Donor transaminase and recipi…Donor Transaminase and Recipient Hepatitis (1981)Donor Transaminase and Recipi…Metagenomics in pooled plasma, with identification of potential emerging infectious pathogens (2017)Metagenomics in pooled plasma…Can the nucleic acid amplification test (NAT) be an alternative to the serologic tests? A prospective study, the results of 18,200 blood donors from the Turkish Red Crescent (2010)Can the nucleic acid amplific…Impact of changes in viral marker screening assays (2003)Impact of changes in viral ma…Reduced frequency of blood donors with false‐positive HIV‐1 and ‐2 antibody EIA reactivity after elution of low‐affinity nonspecific natural antibodies (2002)Reduced frequency of blood do…[Risk of transfusional-transmitted infections]. (2002)[Risk of transfusional-transm…Transmission of Retroviruses by Transfusion of Screened Blood in Patients Undergoing Cardiac Surgery (1989)Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. (2002)Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century (2010)Clinical Decision Analysis (1980)EVALUATING THE COST-EFFECTIVENESS OF CLINICAL AND PUBLIC HEALTH MEASURES (1998)Handling uncertainty when performing economic evaluation of healthcare interventions. (1999)Preference-Based Measures in Economic Evaluation in Health Care (2000)Clinical decision analysis (2005)The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection (1997)Collection and transfusion of blood and blood components in the United States, 1994 (1998)Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996 (2000)Safety of the Blood Supply (1995)Computer-Based Interview for Screening Blood Donors for Risk of HIV Transmission (1992)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Epidemiologic characteristics of blood donors with antibody to human immunodeficiency virus (1988)Screening blood donors for human immunodeficiency virus antibody: cost-benefit analysis. (1988)Sociodemographic and behavioral characteristics of HIV antibody-positive blood donors. (1988)Transfusion-Associated Hepatitis and AIDS (1987)Public health service interagency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C (1991)Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)The risks of transfusion-transmitted infection: direct estimation and mathematical modelling (2000)
this work references cited by second hop

References

  • 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
  • 1988Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV Antibody467 cited
  • 1995Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States346 cited
  • 1989Exposure of Patients to Human Immunodeficiency Virus through the Transfusion of Blood Components That Test Antibody-Negative244 cited
  • 1981Donor transaminase and recipient hepatitis. Impact on blood transfusion services231 cited
  • 1981Donor Transaminase and Recipient Hepatitis192 cited
  • 1991Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV‐1 antibody screening177 cited
  • 1991Evaluation of Screened Blood Donations for Human Immunodeficiency Virus Type 1 Infection by Culture and DNA Amplification of Pooled Cells169 cited
  • 1985Prevalence of HTLV-III Antibody in American Blood Donors127 cited
  • 1995Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study124 cited
  • 1992Transmission of Retroviruses from Seronegative Donors by Transfusion during Cardiac Surgery102 cited

Cited by

  • 2003Impact of changes in viral marker screening assays28 cited
  • 2010Can the nucleic acid amplification test (NAT) be an alternative to the serologic tests? A prospective study, the results of 18,200 blood donors from the Turkish Red Crescent

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

14 cited
  • 2002Reduced frequency of blood donors with false‐positive HIV‐1 and ‐2 antibody EIA reactivity after elution of low‐affinity nonspecific natural antibodies13 cited
  • 2002[Risk of transfusional-transmitted infections].13 cited
  • 2017Metagenomics in pooled plasma, with identification of potential emerging infectious pathogens12 cited